Journal of Hematology & Oncology

official impact factor 2.93

Open Access Highly Access Review

Pharmacological basis and clinical evidence of dabigatran therapy

Santiago Redondo*, Maria-Paz Martínez, Marta Ramajo, Jorge Navarro-Dorado, Abelardo Barez and Teresa Tejerina

Journal of Hematology & Oncology 2011, 4:53 doi:10.1186/1756-8722-4-53

No comments have yet been made on this article.

Post a comment